share_log

EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains

Benzinga Real-time News ·  Jan 23, 2023 11:28

(This is part two of a four-part series)

Check out part one in the series:Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction

A compound developed by Israeli psychedelics company Clearmind Medicine (NASDAQ:CMND) would act by providing a similar feeling to that which drinking alcohol produces.

"It gives you the sensation not only that you've had enough but also you don't want to have any more drinks, while also giving a very warm, very controlled sociable sensation," says CEODr. Adi Zuloff-Shani.

Clearmind has already concluded several preclinical studies on...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment